BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11715228)

  • 1. [Can the action of statins reveal etiology of coronary diseases?].
    Werkö L
    Lakartidningen; 2001 Oct; 98(42):4566-7. PubMed ID: 11715228
    [No Abstract]   [Full Text] [Related]  

  • 2. [The new debate on cholesterol: is the lowest level the best?].
    Olsson AG
    Lakartidningen; 1999 Feb; 96(6):648-52. PubMed ID: 10087815
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and the acute-phase response.
    Munford RS
    N Engl J Med; 2001 Jun; 344(26):2016-8. PubMed ID: 11430332
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating hypercholesterolemia aggressively.
    Wilson CS
    Nebr Med J; 1996 Jan; 81(1):3-4. PubMed ID: 8584066
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol lowering. Should it continue to be the last thing we do?
    Waters D
    Circulation; 1999 Jun; 99(25):3215-7. PubMed ID: 10385491
    [No Abstract]   [Full Text] [Related]  

  • 10. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 11. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholesterol-lowering action of policosanol compares well to that of pravastatin and lovastatin.
    Cardiovasc J S Afr; 2003; 14(3):161. PubMed ID: 12931736
    [No Abstract]   [Full Text] [Related]  

  • 13. Aggressive lipid-lowering regimen halts CHD progression.
    Geriatrics; 2004 Jan; 59(1):44. PubMed ID: 14755869
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of atherosclerosis with aggressive lipid lowering.
    Farmer JA
    Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins and coronary heart disease.
    Thompson GR
    Lancet; 1996 Jul; 348(9019):57. PubMed ID: 8691944
    [No Abstract]   [Full Text] [Related]  

  • 16. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
    Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania PC;
    Am Heart J; 2004 Dec; 148(6):1053-9. PubMed ID: 15632893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

  • 20. Lovastatin to prevent acute coronary events with average cholesterol levels.
    MacFarlane LL; Carek PJ
    J Fam Pract; 1998 Aug; 47(2):91-2. PubMed ID: 9722787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.